Skip to main content
Brady Laughlin, MD, Radiation Oncology, Scottsdale, AZ

BradyLaughlinMD

Radiation Oncology Scottsdale, AZ

Radiation Oncologist at Mayo Clinic Arizona

Dr. Laughlin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Laughlin's full profile

Already have an account?

  • Office

    13400 E Shea Blvd
    Scottsdale, AZ 85259
    Phone+1 480-301-8000

Education & Training

  • Mayo Clinic College of Medicine and Science (Phoenix)
    Mayo Clinic College of Medicine and Science (Phoenix)Residency, Radiation Oncology, 2019 - 2024
  • University of Arizona College of Medicine
    University of Arizona College of MedicineClass of 2019

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2024 - 2026
  • AZ State Medical License
    AZ State Medical License 2020 - 2025
  • CO State Medical License
    CO State Medical License 2024 - 2025
  • NM State Medical License
    NM State Medical License 2024 - 2025
  • OR State Medical License
    OR State Medical License 2024 - 2025
  • TX State Medical License
    TX State Medical License 2024 - 2024

Awards, Honors, & Recognition

  • Member Alpha Omega Alpha Honor Medical Society, 2017

Publications & Presentations

PubMed

Journal Articles

  • Physician and Patient-Reported Outcomes of the MC1635 Phase III Trial of Ultra-Hypofractionated Versus Moderate Hypofractionated Adjuvant Radiotherapy After Breast-Con...  
    Brady S. Laughlin MD , Kimberly A. Corbin MD , Diego Augusto Santos Toesca MD , Cameron S. Thorpe MD , Michael A. Golafshar MS , Barbara Pockaj MD , Patricia Cronin MD..., International Journal of Radiation Oncology, Biology, Physics, 10/30/2023

Lectures

  • Clinical outcome associated with neoadjuvant chemoradiation and orthotopic liver transplantation versus definitive chemoradiation in 49 patients with unresectable, hil... 
    ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020